These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3535159)

  • 1. Cellular localisation in placenta of placental type plasminogen activator inhibitor.
    Astedt B; Hägerstrand I; Lecander I
    Thromb Haemost; 1986 Aug; 56(1):63-5. PubMed ID: 3535159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta.
    Philips M; Juul AG; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1986 Apr; 55(2):213-7. PubMed ID: 2424117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific plasminogen activator inhibitor of placental type PAI 2 occurring in amniotic fluid and cord blood.
    Lecander I; Astedt B
    J Lab Clin Med; 1987 Nov; 110(5):602-5. PubMed ID: 3499478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against pregnancy-specific beta 1-glycoprotein (SP1) in immunohistochemistry and radioimmunoassay.
    Wahlström T; Heikinheimo M
    Oncodev Biol Med; 1983; 4(6):423-7. PubMed ID: 6196757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the immunohistochemical localization of coagulation fibrinolysis factors in the placenta, especially of placental plasminogen activator (PPA)].
    Kyodo Y; Kobayashi T; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):10-6. PubMed ID: 3512741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pregnancy-associated proteins].
    Pasty N; Rousselet F
    Ann Biol Clin (Paris); 1982; 40(4):303-14. PubMed ID: 6183995
    [No Abstract]   [Full Text] [Related]  

  • 8. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators.
    Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC
    Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma.
    Lecander I; Astedt B
    Br J Haematol; 1986 Feb; 62(2):221-8. PubMed ID: 3484964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in analysis of oncoplacental protein SP1 in vivo and in vitro.
    Engvall E; Miyashita M; Ruosiahti E
    Cancer Res; 1982 May; 42(5):2028-33. PubMed ID: 6175403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA Class I protein expression in the human placenta.
    Blaschitz A; Hutter H; Dohr G
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and cellular localisation of chloride intracellular channel 3 in human placenta and fetal membranes.
    Money TT; King RG; Wong MH; Stevenson JL; Kalionis B; Erwich JJ; Huisman MA; Timmer A; Hiden U; Desoye G; Gude NM
    Placenta; 2007; 28(5-6):429-36. PubMed ID: 17027078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide induces the expression of interleukin-1alpha distinctly in different compartments of term and preterm human placentae.
    Huleihel M; Amash A; Sapir O; Maor E; Levy S; Katz M; Dukler D; Myatt L; Holcberg G
    Eur Cytokine Netw; 2004; 15(1):30-6. PubMed ID: 15217750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low oxygen concentrations inhibit trophoblast cell invasion from early gestation placental explants via alterations in levels of the urokinase plasminogen activator system.
    Lash GE; Otun HA; Innes BA; Bulmer JN; Searle RF; Robson SC
    Biol Reprod; 2006 Feb; 74(2):403-9. PubMed ID: 16251495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular localisation of the pregnancy-associated glycoprotein family (PAGs) in the synepitheliochorial placenta of the European bison.
    Majewska M; Panasiewicz G; Szafranska B; Gizejewski Z; Majewski M; Borkowski K
    Gen Comp Endocrinol; 2008 Jan; 155(2):422-31. PubMed ID: 17854806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
    Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
    Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A search for human placental-type alkaline phosphatases using monoclonal antibodies.
    McLaughlin PJ; Johnson PM
    Prog Clin Biol Res; 1984; 166():67-75. PubMed ID: 6390460
    [No Abstract]   [Full Text] [Related]  

  • 18. Retinoid binding proteins-expression patterns in the human placenta.
    Johansson S; Gustafson AL; Donovan M; Eriksson U; Dencker L
    Placenta; 1999; 20(5-6):459-65. PubMed ID: 10419811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical localization of pregnancy-specific beta 1-globulin in placentas at various ages].
    Friedman W; Cramer B; Vogel M; Baumgärtel H
    Z Geburtshilfe Perinatol; 1984; 188(3):119-22. PubMed ID: 6206661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage populations in the human placenta and amniochorion.
    Bulmer JN; Johnson PM
    Clin Exp Immunol; 1984 Aug; 57(2):393-403. PubMed ID: 6380834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.